OXYTOCIN GH Solution for Injection 5 IU/ 1 mL ampoule Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

oxytocin gh solution for injection 5 iu/ 1 ml ampoule

generic health pty ltd - oxytocin, quantity: 5 iu/ml - injection, solution - excipient ingredients: water for injections; sodium acetate; sodium chloride; glacial acetic acid - induction of labour; inadequate uterine effort; management of third stage of labour; post-partum haemorrhage.

GLYPRESSIN SOLUTION terlipressin 0.85 mg/8.5 mL solution for injection ampoule Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

glypressin solution terlipressin 0.85 mg/8.5 ml solution for injection ampoule

ferring pharmaceuticals pty ltd - terlipressin, quantity: 0.85 mg - injection, solution - excipient ingredients: sodium chloride; water for injections; sodium acetate trihydrate; acetic acid - glypressin is indicated for the:,?treatment of bleeding oesophageal varices (bov);,?treatment of patients with type 1 hepatorenal syndrome (hrs) who are actively beingconsidered for liver transplant.

EVICEL SOLUTION Կանադա - անգլերեն - Health Canada

evicel solution

omrix biopharmaceuticals ltd - fibrinogen (human); thrombin (human) - solution - 90mg; 1200unit - fibrinogen (human) 90mg; thrombin (human) 1200unit - hemostatics

VISTASEAL SOLUTION Կանադա - անգլերեն - Health Canada

vistaseal solution

instituto grifols s.a. - fibrinogen (human); thrombin (human) - solution - 80mg; 500unit - fibrinogen (human) 80mg; thrombin (human) 500unit - hemostatics

VISTASEAL SOLUTION Կանադա - անգլերեն - Health Canada

vistaseal solution

instituto grifols s.a. - fibrinogen (human); thrombin (human) - solution - 160mg; 1000unit - fibrinogen (human) 160mg; thrombin (human) 1000unit - hemostatics

VISTASEAL SOLUTION Կանադա - անգլերեն - Health Canada

vistaseal solution

instituto grifols s.a. - fibrinogen (human); thrombin (human) - solution - 400mg; 2500unit - fibrinogen (human) 400mg; thrombin (human) 2500unit - hemostatics

FIBRYGA, 1 g, powder and solvent for solution for injection/infusion Իռլանդիա - անգլերեն - HPRA (Health Products Regulatory Authority)

fibryga, 1 g, powder and solvent for solution for injection/infusion

octapharma (ip) sprl - human fibrinogen - powder and solvent for solution for injection/infusion - 1 gram(s) - fibrinogen, human

Oticon Amigo system Սինգապուր - անգլերեն - HSA (Health Sciences Authority)

oticon amigo system

oticon singapore pte ltd - ear, nose & throat - the fm receiver is intended as a wireless receiver and transmitter of sound between hearing instruments and the surrounding environment, including speech and wireless electronic audio devices. the fm receiver is intended to be used by infants, children and adults together with their hearing solution.

Riastap 1 g  Powder for Solution for Injection / Infusion Իռլանդիա - անգլերեն - HPRA (Health Products Regulatory Authority)

riastap 1 g powder for solution for injection / infusion

csl behring gmbh - human fibrinogen - powder for solution for injection/infusion - 1 gram(s) - fibrinogen; fibrinogen, human

TISSEEL- fibrinogen human and thrombin human 
TISSEEL FROZEN- fibrinogen human and thrombin human solution Ամերիկայի Միացյալ Նահանգներ - անգլերեն - NLM (National Library of Medicine)

tisseel- fibrinogen human and thrombin human tisseel frozen- fibrinogen human and thrombin human solution

baxalta us inc. - fibrinogen human (unii: n94833051k) (fibrinogen human - unii:n94833051k) - fibrinogen human 90 mg in 1 ml - tisseel is a fibrin sealant indicated for use as an adjunct to hemostasis in adult and pediatric patients (>1 month of age) undergoing surgery when control of bleeding by conventional surgical techniques (such as suture, ligature, and cautery) is ineffective or impractical. tisseel is effective in heparinized patients. tisseel is a fibrin sealant indicated as an adjunct to standard surgical techniques (such as suture and ligature) to prevent leakage from colonic anastomoses following the reversal of temporary colostomies. do not inject tisseel directly into the circulatory system or into highly vascularized tissue. intravascular application of tisseel can lead to intravascular coagulation, can result in life-threatening thromboembolic events, and can increase the likelihood and severity of acute hypersensitivity reactions in susceptible patients (see warnings and precautions(5.3) and adverse reactions (6.2)).   do not use tisseel in individuals with a known hypersensitivity to aprotinin  (see warnings and pre